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Differences in color of the skin and hair of animals have been the subject of
much research. Such differences have been ascribed partly to differences in the
relative amounts of dark eumelanins, and lighter pigments, phaeomelanins, in the
pigmented tissues. The chemistry of eumelanins has been extensively discussed in
the classic monograph of Nicolaus (1). The early work of Prota and Nicolaus
suggested that phaeomelanins were derived from tyrosine and cysteine (2). All
later studies lent support to their view. At the VIIth International Pigment Cell
Conference in Seattle in 1969, Prota presented the review "Structure and biogenesis
of phaeomelanins" (3), which summarizes the very important work in this field
from the Department of Organic Chemistry in the University of Naples.
In 1966 two catechols giving different fluorophores when oxidized were de-
scribed in human melanomas (4-6). One of them proved to be dopa, while the
other remained unidentified for many years. Recent work has shown that this sec-
ond catechol is 5-S-cysteinyldopa (7-9), the compound considered to be the build-
ing-stone of phaeomelanins.
This review concerns studies on 5-S-cysteinyldopa, which suggest that determina-
tion of this thiocatechol may be helpful in the definition of pigment metabolism
in health and in disease.
METHODS FOR DETECTING 5-S-CYSTEINYLDOPA
Fluorimetric methods are available for detecting 5-S-cysteinyldopa in biologi-
cal specimens (7, 8). 5-S-cysteinyldopa is extracted with perchloric acid and is
readily adsorbed to aluminum. It can be separated from other catechols by chroma-
tography (8).
When treated with formaldehyde 5-S-cysteinyldopa forms a fluorophore differing
in fluorescence from those formed by most other catechols (7, 8). Oxidation of
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FIG. 1. Excitation and emission maxima of the fluorophore produced by iodine oxidation
of 5-S-cysteinyldopa (10).
TABLE 1
SCHEDULE FOR D)ETERMINATION OF 5-S-CYSTEINYLDOI'A (10)
'I'issue Reagenit
Voluimies in nil Standard Saiimple blaink blank
13Btffer, 0.b) Af acetate buffer, pH 4.0 0.20 0. 20 0.20 0. 20
1l,luate 0.i20 0.120
Cysteinyldopa 0.5 jAg/mIl 0.20
1120 0.80 0.80 1.05 1.00
I. Io(Iinie solution, 0.02 Na 0.05 0.05 - 0.05
II. 5 N NaOIL added 2 min after I 0.20 0.20 0.20 0.20
III. 10 N acetic aci(d added 2 miii after II 0.50 0.50 0.50 0.50
0.i2 ,If sodium sulfite 0.120 0.0 - 0.20
a Dissolve 0.254 g iodiiie anid 5 g KI in 100 ml 120.
5-S-cysteinyldopa according to Anton and Sayre (6) results in the formation of
two different fluorophores (7-9). Extensive investigation of the conditions neces-
sary for obtaining the two different fluorophores have led to the elaboration of
methods for selectively producing the two fluorophores by the use of different oxi-
dation procedures. The most sensitive and specific oxidation reaction results in
the formation of a fluorophore with an excitation maximum at 325 and emission
maximum at 405 nm (10) (see Fig. 1). The schedule for this 5-S-cysteinyldopa
method is given in Table 1. Among 20 different catechol- and indolderivatives ex-
amined only a cysteinyldopa peptide was found to interfere with the 5-S-cys-
teinyldopa determination (10).
DOPA AND 5-S-CYSTEINYLDOPA IN THE NORMAL SKIN AND IN
HAIRS OF DIFFERENT COLOR OF GUINEA PIGS
Black, white and yellow-red skin of multicolored guinea pigs was clipped with
scissors and the hair was extracted with 0.4 N perchloric acid. The remaining hair
was shaved off and the skin specimens were also extracted. The extracts were
treated in the way described previously and dopa and 5-S-cysteinyldopa were deter-
mined fluorimetrically (6, 10).
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TABLE 2
DOPA AND 5-S-CYSTEINYLDOPA IN THE SKIN AND HAIRS OF GUINEA PIGS
Dopa ,g/g 5-S-cysteinyldopa,g/g
Tissue Nuimbere Mean value Range Mean value Range
Red skin 4 0.10 0.05-0.15 0.25 0.19-0.41
Red hair 5 2.03 1.49-2.69 0.86 0.61-1.06
Black skin 3 0.09 0.04-0.12 0.04 0.02-0.06
Black hair 3 1.53 0.84-2.14 0.09 0.05-0.12
White skin 3 0.05 0.01-0.10 0.01 0.00-0.01
White hair 4 0.15 0.12-0.18 0.00 0.00-0.00
Table 2 gives the quantities of cysteinyldopa and dopa found extracted from
the skin and hairs of the respective colors. It is evident that the amount of catechol
in the white skin and the white hairs was very small. In the black skin the amounts
of cysteinyldopa and dopa were rather small, but in the black hairs the dopa values
were much higher than those found for 5-S-cysteinyldopa. The skin with red hair
and the red hairs contained much more 5-S-cysteinyldopa than the black skin and
black hair. The amounts of dopa, however, were similar to those in black skin
and black hairs.
Dopa has previously been detected in the skin and in hairs of pigmented guinea
pigs (11) while 5-S-cysteinyldopa has not previously been found in the normal
tissues.
Dopa and cysteinyldopa are presumably present mainly in tissues containing
melanin-forming organelles. The concentrations of catechols in the hairs were
higher than in the skin consisting of dermis with hair follicles and epidermis. Pig-
ment formation is minimal in the epidermal melanocytes in guinea pigs and the
epidermis probably contained only a very minor portion of the catechols. The
hair follicles with their rapid synthesis of pigment might be expected to contain
catechols. The presence of catechols in the fully keratinized hairs may seem sur-
prising, but it may, however, be explained by the assumption that the hair keratino-
cytes ingest premelanosomes together with the melanosomes.
5-S-CYSTEINYLDOPA IN HARDING-PASSEY MELANOMAS
Previous investigations have shown the presence of free dopa in Harding-Passey
melanoma (12, 5). With the new fluorimetric method it has also been possible
to demonstrate 5-S-cysteinyldopa in Harding-Passey tumors. The quantity of
5-S-cysteinyldopa extracted from 10 Harding-Passey melanomas was on the aver-
age 1.4 tug/g tissue, which is a concentration of the same order as that of dopa
in these tumors.
CATECHOLS IN THE URINE IN MICE WITH HARDING-PASSEY
MELANOMAS
Mice inoculated 3 wk previously with Harding-Passey melanomas showed a pro-
found change in the urinary catechols (see Table 3). 5-S-cysteinyldopa was mark-
5185-S-CYSTEINYLDOPA IN MELANOMAS 519
TABLE 3
D)oPA, DOPAMINE (D)A) AND 55-S-CYSTEINYLDOPA (CD) IN POOLED URINE OF 10
CONTROL AMICE AND 10 MICE WITH IIARDING-PASSEY MELANOMAS
Dopa D)A CD
/Ag/Ml ,AgIM:rl /g/Ml
Controls 0.05 0.30 0.04
Melanoma animals 0.06 18 12
TABLE 4
5-S-CYSTEINYLDOPA (,Ug/g) IN AIELANOMAS OF CAUCASIANS AND NEGROES (14, 15)
Mean value Range
Caucasians 18.5 0.6-61
Negroes 2.8 0.0-8.9
TABLE 5
D)OPA, DOIPANIINE AND 5-S-CYSTEINYLDOPA IN TILE URINE OF HEALTIIY SUBJECTS
AND OF PATIENTS WITII AIELANOMAS (16)
Number Dopa,g/ml DA Ag/ml CD Ag/ml
Conitrols 10 0.00-0.02 0.12-0.37 0.00-0.04
Patieiits with melanioma
metastases 4 0.00-0.07 0.11-0.61 0.32-1.4(0
Patienits with excised mela-
nomias without metastascs 2 0.00 0.12-0.17 0.02
edly increased and dopamine was present in very large amounts. Since Hard-
ing-Passey melanomas do not contain dopamine (5) the large amounts of
dopamine in the urine of tumor-bearing animals must have been due to leakage
of dopa and/or of tyrosinase from the tumors. Dopa, formed inside or outside
the tumor reaching the kidney, should to a large extent be decarboxylated and
excreted as dopamine or its oxidation products (13).
5-S-CYSTEINYLDOPA IN HUMAN MELANOMAS
5-S-cysteinyldopa has been demonstrated in melanomas from persons with red
hair as well as in melanomas from persons with other complexions (9, 14). It
is remarkable that this sulfur-containing catechol is present in melanomas in many
Negroes (15), indicating the existence of a phaeomelanin pathway also in very
dark subjects, at least under pathologic conditions. The mean values and ranges
of 5-S-cysteinyldopa in melanomas of Caucasians and Negroes are given in Table
4. The highest concentrations were observed in Caucasians with red hair. Some
melanomas in Negroes contained more 5-S-cysteinyldopa than did Caucasian mela-
nomas, but in other Negro melanomas no cysteinyldopa was found.RORSMAN, ROSENGREN, AND ROSENGREN
5-S-CYSTEINYLDOPA IN THE URINE IN PATIENTS WITH
MELANOMA METASTASES
The new fluorimetric method for determining 5-S-cysteinyldopa has made it
possible to quantitate this substance in the urine. Table 5 gives the amounts of
dopa, dopamine and cysteinyldopa in the urine of controls and of melanoma pa-
tients. The excretion of 5-S-cysteinyldopa is pronounced in patients with known
melanoma metastases, but normal in those without clinical signs of metastases
(16). Since the urinary excretion of 5-S-cysteinyldopa may be normal in the pa-
tients with amelanotic melanoma metastases, determination of 5-S-cysteinyldopa
seems to be informative only in those cases where it is excreted in increased
amounts.
Dopa is a substance, which, if present in large amount in the urine, may be
a sign of the existence of malignant melanocytes, forming eumelanin. Increased
urinary excretion of dopa (17-20) and dopamine (19, 20), the decarboxylation
product of dopa, has been reported in patients with melanoma, but determination of
5-S-cysteinyldopa seems to be the most sensitive methed for demonstrating the
presence of melanoma in Caucasians, since the excretion of dopa and dopamine
was normal in many of our patients with increased excretion of 5-S-cysteinyldopa.
DISCUSSION
The pigment chemists of Naples have produced convincing evidence that
5-S-cysteinyldopa plays an important role in the formation of phaeomelanin. The
occurrence of this catechol in the body has now also been demonstrated.
The new oxidation method for determining 5-S-cysteinyldopa makes it possible
to define the distribution of this catechol in normal and diseased pigment-forming
tissues.
The method will certainly find many applications in pigment research. It will
be helpful in analysing the pigment-forming system and then, not by studies of
the pigmented end products which are often very difficult to decompose, but by
quantitation of one of the important molecules forming the pigment. Classification
of human and experimental melanomas on the basis of their relative amounts of
dopa and 5-S-cysteinyldopa and investigations for any correlation with histologic
and clinical findings would be welcome.
For problems related to pigment-cell genetics the method will open up new ap-
proaches to the analysis of the simultaneous formation of eumelanin and phaeo-
melanin. The possibilities of determining 5-S-cysteinyldopa in urine may be helpful
in defining the pigment formation in a given person. The preliminary results in
patients with melanoma metastases suggest that the analysis of 5-S-cysteinyldopa
in the urine may be of practical clinical value in the diagnosis and follow-up of
patients with melanoma.
SUMMARY
A sensitive fluorometric method for determination of 5-S-cysteinyldopa has been
used in investigations of pigment formation.
The results indicate that this thiocatechol is an important intermediate substance
in many types of pigment synthesis. Thus 5-S-cysteinyldopa is found in the hair
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follicles and in the keratinized red and black hairs of guinea pigs. 5-S-cysteinyldopa
occurs in Harding-Passey melanomas of mice as well as in the urine in tumor-bear-
ing animals.
5-S-cysteinyldopa has been detected in all Caucasian melanomas examined. The
highest concentrations have been found in melanomas in patients with red hair.
Also many melanomas in Negroes contain 5-S-cysteinyldopa.
Determination of catechols in urine in patients with melanoma metastases has
shown that 5-S-cysteinyldopa may be present in large amounts in spite of normal
excretion of dopa and dopamine.
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